NEUROLEPTIC-INDUCED VACUOUS CHEWING MOVEMENTS IN RODENTS - INCIDENCE AND EFFECTS OF LONG-TERM INCREASES IN HALOPERIDOL DOSE

被引:22
作者
EGAN, MF [1 ]
HYDE, TM [1 ]
KLEINMAN, JE [1 ]
WYATT, RJ [1 ]
机构
[1] NIMH,NEUROSCI CTR ST ELIZABETHS,CLIN BRAIN DISORDERS BRANCH,WASHINGTON,DC 20032
关键词
TARDIVE DYSKINESIA; RATS; HALOPERIDOL; VACUOUS CHEWING MOVEMENTS;
D O I
10.1007/BF02245101
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rats treated chronically with neuroleptics develop vacuous chewing movements (VCMs), similar in some respects to tardive dyskinesia (TD) in man. The VCM syndrome was used as a model of TD to examine the ability of increased neuroleptic doses to produce long-term suppression of dyskinetic movements. The incidence and persistence of the VCM syndrome in individual rats were also assessed to look for affected and unaffected subgroups. Rats were initially treated for 15 weeks with haloperidol decanoate. For the next 21 weeks, half the group received a 50-150% increase in dose while the other half continued to receive the same dose. Animals were also followed during a 28-week withdrawal period. Total VCM ratings showed a skewed distribution, with some rats exhibiting few movements while others developed marked and persistent movements. Increasing doses did not suppress VCMs, nor did they exacerbate movements during the withdrawal period. To the extent that the VCM syndrome models TD, the absence of long-term suppression of the VCM syndrome suggests that, at this dosage range, increasing depot neuroleptic doses may not be a useful long-term strategy for TD suppression.
引用
收藏
页码:74 / 81
页数:8
相关论文
共 52 条
[1]  
*AM PSYCH ASS TASK, 1992, TARD DYSK
[2]   VARIATION IN ORO-FACIAL TARDIVE-DYSKINESIA DURING DEPOT ANTI-PSYCHOTIC DRUG-TREATMENT [J].
BARNES, TRE ;
WILES, DH .
PSYCHOPHARMACOLOGY, 1983, 81 (04) :359-362
[3]   METHODS AND THEORY OF RELIABILITY [J].
BARTKO, JJ ;
CARPENTER, WT .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1976, 163 (05) :307-317
[4]   THE COURSE OF TARDIVE-DYSKINESIA IN PATIENTS ON LONG-TERM NEUROLEPTICS [J].
BERGEN, JA ;
EYLAND, EA ;
CAMPBELL, JA ;
JENKINGS, P ;
KELLEHEAR, K ;
RICHARDS, A ;
BEUMONT, PJV .
BRITISH JOURNAL OF PSYCHIATRY, 1989, 154 :523-528
[5]   MANAGEMENT OF TARDIVE DYSKINESIA WITH THIOPROPAZATE [J].
CURRAN, JP .
AMERICAN JOURNAL OF PSYCHIATRY, 1973, 130 (08) :925-927
[6]  
DOONGAJI DR, 1982, J CLIN PSYCHOPHARM, V2, P376
[7]  
EGAN MF, 1992, AM J PSYCHIAT, V149, P773
[8]  
FARDE L, 1992, ARCH GEN PSYCHIAT, V49, P538
[9]  
Frangos E, 1975, Acta Psychiatr Belg, V75, P19
[10]   CHRONIC BLOCKADE OF DOPAMINE-RECEPTORS BY ANTI-SCHIZOPHRENIC DRUGS ENHANCES GABA BINDING IN SUBSTANTIA NIGRA [J].
GALE, K .
NATURE, 1980, 283 (5747) :569-570